{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-059690","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.432853+00:00","generated_at":"2026-05-18T13:26:29.545560+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"INmune Bio raises ~$19M in registered direct offering of 3M shares at $6.30/sh","bullets":["Offering of 3,000,000 common shares at $6.30/share to two healthcare-focused institutional investors.","Gross proceeds of approximately $19 million; net proceeds for working capital and general corporate purposes.","A.G.P./Alliance Global Partners acted as sole placement agent; 7% cash fee paid.","Pricing announced June 27, 2025; closing occurred June 30, 2025.","Shares offered under effective shelf registration statement (Form S-3, File No. 333-279036)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-059690","json":"https://secwatch.observer/filing/0001213900-25-059690.json","markdown":"https://secwatch.observer/filing/0001213900-25-059690.md","text":"https://secwatch.observer/filing/0001213900-25-059690.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025059690/0001213900-25-059690-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025059690/ea0247461-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T13:26:29.545560+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}